Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

OTC Monograph Application Reviews Get Deadlines, Not GRASE Flexibility

Nov 30 2016

• By Malcolm Spicer

Related Content

“No End In Sight” For Completing OTC Monographs – CDER Director Woodcock

Mar 26 2014

FDA Proposes Illuminating OTC Monograph Process With Sunscreen TEA Framework

Apr 01 2016

OTC Regulatory Pathway Needs NDA Flexibility, Monograph Scope – Sharfstein

Jul 30 2015

FDA Sunscreen Guidance: Absorption Data Is A MUsT For GRASE Review

Nov 28 2016

FDA Adds OTC Monograph Staff By Shifting CDER Appropriations

Oct 07 2016

Additional Topics

United States Drug Approval Standards Regulation FDA OTC Drugs Consumer

More from Approval Standards

More from Pathways & Standards

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window